Outcomes of Radiotherapy in Oligoprogressive Breast Cancer.

J Pers Med · 2024 · PMC11355129 · PMID 39201997

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

a positive trendp = 0.07so close (0.05 < p ≤ 0.1)

Standardizing doses by converting them to biologically effective doses (BEDs) at α/β = 4 and α/β = 10 did not reveal a clear advantage for specific dose levels in treating oligoprogressive sites, with the exception of a positive trend towards improved PFS-AR in patients treated with BED > 75 Gy at α/β = 4 ( p = 0.07).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.